Myeloid-derived suppressor cells (MDSCs): what do we currently know about the effect they have against anti-PD-1/PD-L1 therapies?

Recent advances in cancer treatment such as PD-1/PD-L1 checkpoint inhibitors have prompted multiple research studies to determine all of the factors that influence response or failure to these new treatments. One of those identified factors is myeloid-derived suppressor cells (MDSCs). These cells we...

Descripción completa

Detalles Bibliográficos
Autores principales: Tellez, Ronald Sergio Limón, Reynolds, Lucia, Piris, Miguel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310335/
https://www.ncbi.nlm.nih.gov/pubmed/37396098
http://dx.doi.org/10.3332/ecancer.2023.1556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310335/
https://www.ncbi.nlm.nih.gov/pubmed/37396098
http://dx.doi.org/10.3332/ecancer.2023.1556

Ejemplares similares